{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:29:43Z","timestamp":1792794583743,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T00:00:00Z","timestamp":1660348800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T00:00:00Z","timestamp":1660348800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82072248"],"award-info":[{"award-number":["82072248"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82072248"],"award-info":[{"award-number":["82072248"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"1.3.5 Project for Disciplines of Excellence, West China Hospital, Sichuan University","award":["ZY2016201"],"award-info":[{"award-number":["ZY2016201"]}]},{"name":"1.3.5 Project for Disciplines of Excellence, West China Hospital, Sichuan University","award":["ZY2016201"],"award-info":[{"award-number":["ZY2016201"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Microbiol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The prevalence of <jats:italic>Helicobacter pylori<\/jats:italic> antibiotic susceptibility in the Tibet Autonomous Region, China is not determined. This study aimed to evaluate the antibiotic resistance patterns of <jats:italic>H. pylori<\/jats:italic> isolates there.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 153 (38.5%) <jats:italic>H. pylori<\/jats:italic> strains were successfully isolated from 397 patients in People's Hospital of Tibet Autonomous Region, China. The overall resistance rates were as follows: clarithromycin (27.4%), levofloxacin (31.3%), metronidazole (86.2%), amoxicillin (15.6%), tetracycline (0%), furazolidone (0.6%), and rifampicin (73.2%). Only 2.0% of <jats:italic>H. pylori<\/jats:italic> isolates were susceptible to all tested antimicrobials, with mono resistance, dual resistance, triple resistance, quadruple resistance, and quintuple resistance being 18.3%, 44.4%, 18.3%, 12.4%, and 4.6%, respectively. The resistance rates to levofloxacin (40.5%) and amoxicillin (21.5%) in strains isolated from female patients were significantly higher than those from male patients (21.6% and 9.5%, respectively).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This study demonstrates high <jats:italic>H. pylori<\/jats:italic> resistance rates to clarithromycin, levofloxacin, metronidazole, and rifampicin, whereas moderate resistance to amoxicillin, and negligible resistant to tetracycline, and furazolidone in Tibet Autonomous Region, China. The high resistance to rifampicin warns further investigation of its derivative, rifabutin.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12866-022-02613-y","type":"journal-article","created":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T09:03:12Z","timestamp":1660381392000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Antibiotic resistance patterns of Helicobacter pylori strains isolated from the Tibet Autonomous Region, China"],"prefix":"10.1186","volume":"22","author":[{"given":"Xiaoqiong","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhonghua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yalin","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaona","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Benghezal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry J.","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,13]]},"reference":[{"issue":"1","key":"2613_CR1","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1136\/gutjnl-2016-312288","volume":"66","author":"P Malfertheiner","year":"2017","unstructured":"Malfertheiner P, Megraud F, O\u2019Morain CA, Gisbert JP, Kuipers EJ, Axon AT, et al. Management of Helicobacter pylori infection-the maastricht V\/Florence consensus report. Gut. 2017;66(1):6\u201330.","journal-title":"Gut"},{"issue":"9","key":"2613_CR2","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1136\/gutjnl-2015-309252","volume":"64","author":"K Sugano","year":"2015","unstructured":"Sugano K, Tack J, Kuipers EJ, Graham DY, El-Omar EM, Miura S, et al. Kyoto global consensus report on Helicobacter pylori gastritis. Gut. 2015;64(9):1353\u201367.","journal-title":"Gut"},{"issue":"2","key":"2613_CR3","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.canlet.2013.08.016","volume":"345","author":"F Wang","year":"2014","unstructured":"Wang F, Meng W, Wang B, Qiao L. Helicobacter pylori-induced gastric inflammation and gastric cancer. Cancer lett. 2014;345(2):196\u2013202.","journal-title":"Cancer lett"},{"issue":"1","key":"2613_CR4","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1053\/j.gastro.2016.04.006","volume":"151","author":"CA Fallone","year":"2016","unstructured":"Fallone CA, Chiba N, van Zanten SV, Fischbach L, Gisbert JP, Hunt RH, et al. The Toronto consensus for the treatment of Helicobacter pylori infection in adults. Gastroenterology. 2016;151(1):51-69.e14.","journal-title":"Gastroenterology"},{"issue":"2","key":"2613_CR5","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/ajg.2016.563","volume":"112","author":"WD Chey","year":"2017","unstructured":"Chey WD, Leontiadis GI, Howden CW, Moss SF. ACG clinical guideline: treatment of Helicobacter pylori Infection. Am J Gastroenterol. 2017;112(2):212\u201339.","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"2613_CR6","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1080\/17474124.2018.1496017","volume":"12","author":"S Flores-Trevino","year":"2018","unstructured":"Flores-Trevino S, Mendoza-Olazaran S, Bocanegra-Ibarias P, Maldonado-Garza HJ, Garza-Gonzalez E. Helicobacter pylori drug resistance: therapy changes and challenges. Expert Rev Gastroent. 2018;12(8):819\u201327.","journal-title":"Expert Rev Gastroent"},{"issue":"2","key":"2613_CR7","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/S1473-3099(17)30005-1","volume":"17","author":"M Montes","year":"2017","unstructured":"Montes M, Perez-Trallero E. How long until routine Helicobacter pylori antimicrobial susceptibility testing? Lancet Infect Dis. 2017;17(2):130\u20131.","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"2613_CR8","doi-asserted-by":"publisher","first-page":"e12597","DOI":"10.1111\/hel.12597","volume":"24","author":"M Kato","year":"2019","unstructured":"Kato M, Ota H, Okuda M, Kikuchi S, Satoh K, Shimoyama T, et al. Guidelines for the management of Helicobacter pylori infection in Japan: 2016 Revised Edition. Helicobacter. 2019;24(4):e12597.","journal-title":"Helicobacter"},{"issue":"10","key":"2613_CR9","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/S2468-1253(17)30219-4","volume":"2","author":"YT Kuo","year":"2017","unstructured":"Kuo YT, Liou JM, El-Omar EM, Wu JY, Leow AHR, Goh KL, et al. Primary antibiotic resistance in Helicobacter pylori in the Asia-Pacific region: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2017;2(10):707\u201315.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"5","key":"2613_CR10","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1053\/j.gastro.2018.07.007","volume":"155","author":"A Savoldi","year":"2018","unstructured":"Savoldi A, Carrara E, Graham DY, Conti M, Tacconelli E. Prevalence of antibiotic resistance in Helicobacter pylori: a systematic review and meta-analysis in World Health Organization regions. Gastroenterology. 2018;155(5):1372-82.e17.","journal-title":"Gastroenterology"},{"issue":"12","key":"2613_CR11","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1016\/j.dld.2014.08.038","volume":"46","author":"Z Song","year":"2014","unstructured":"Song Z, Zhang J, He L, Chen M, Hou X, Li Z, et al. Prospective multi-region study on primary antibiotic resistance of Helicobacter pylori strains isolated from Chinese patients. Digest Liver Dis. 2014;46(12):1077\u201381.","journal-title":"Digest Liver Dis"},{"issue":"5","key":"2613_CR12","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1007\/s10620-017-4536-8","volume":"62","author":"Y Hu","year":"2017","unstructured":"Hu Y, Zhu Y, Lu NH. Primary antibiotic resistance of Helicobacter pylori in China. Digest Dis Sci. 2017;62(5):1146\u201354.","journal-title":"Digest Dis Sci"},{"issue":"4","key":"2613_CR13","doi-asserted-by":"publisher","first-page":"e22339","DOI":"10.1002\/jcla.22339","volume":"32","author":"Y Shao","year":"2018","unstructured":"Shao Y, Lu R, Yang Y, Xu Q, Wang B, Ye G. Antibiotic resistance of Helicobacter pylori to 16 antibiotics in clinical patients. J Clin Lab Anal. 2018;32(4):e22339.","journal-title":"J Clin Lab Anal"},{"issue":"1","key":"2613_CR14","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s12866-019-1517-4","volume":"19","author":"D Wang","year":"2019","unstructured":"Wang D, Guo Q, Yuan Y, Gong Y. The antibiotic resistance of Helicobacter pylori to five antibiotics and influencing factors in an area of China with a high risk of gastric cancer. BMC Microbiol. 2019;19(1):152.","journal-title":"BMC Microbiol"},{"key":"2613_CR15","doi-asserted-by":"crossref","unstructured":"Ren S, Cai P, Liu Y, Wang T, Zhang Y, Li Q, et al. Prevalence of Helicobacter pylori infection in China: A systematic review and meta-analysis. J Gastroen Hepatol. 2022;37(3):464-70.","DOI":"10.1111\/jgh.15751"},{"issue":"4","key":"2613_CR16","doi-asserted-by":"publisher","DOI":"10.1111\/hel.12703","volume":"25","author":"X Tang","year":"2020","unstructured":"Tang X, Shen Y, Hu R, Yang T, Benghezal M, Li H, et al. Re-assessment of the disk diffusion technique for routine antimicrobial susceptibility testing for Helicobacter pylori. Helicobacter. 2020;25(4): e12703.","journal-title":"Helicobacter"},{"key":"2613_CR17","volume-title":"Disk diffusion method. Version 5.0","author":"The European Committee on Antimicrobial Susceptibility Testing","year":"2020","unstructured":"The European Committee on Antimicrobial Susceptibility Testing. Disk diffusion method. Version 5.0. 2020."},{"issue":"4","key":"2613_CR18","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1590\/S1517-83822014000400039","volume":"45","author":"SK Ogata","year":"2014","unstructured":"Ogata SK, Gales AC, Kawakami E. Antimicrobial susceptibility testing for Helicobacter pylori isolates from Brazilian children and adolescents: comparing agar dilution, e-test, and disk diffusion. Braz J Micorbiol. 2014;45(4):1439\u201348.","journal-title":"Braz J Micorbiol"},{"issue":"10","key":"2613_CR19","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1136\/gutjnl-2021-324032","volume":"70","author":"F Megraud","year":"2021","unstructured":"Megraud F, Bruyndonckx R, Coenen S, Wittkop L, Huang TD, Hoebeke M, et al. Helicobacter pylori resistance to antibiotics in Europe in 2018 and its relationship to antibiotic consumption in the community. Gut. 2021;70(10):1815\u201322.","journal-title":"Gut"},{"issue":"9","key":"2613_CR20","doi-asserted-by":"publisher","first-page":"2786","DOI":"10.3748\/wjg.v21.i9.2786","volume":"21","author":"YX Zhang","year":"2015","unstructured":"Zhang YX, Zhou LY, Song ZQ, Zhang JZ, He LH, Ding Y. Primary antibiotic resistance of Helicobacter pylori strains isolated from patients with dyspeptic symptoms in Beijing: a prospective serial study. World J Gastroenterol. 2015;21(9):2786\u201392.","journal-title":"World J Gastroenterol"},{"issue":"11\u201312","key":"2613_CR21","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1111\/apt.12089","volume":"36","author":"CY Tay","year":"2012","unstructured":"Tay CY, Windsor HM, Thirriot F, Lu W, Conway C, Perkins TT, et al. Helicobacter pylori eradication in Western Australia using novel quadruple therapy combinations. Aliment Pharm Ther. 2012;36(11\u201312):1076\u201383.","journal-title":"Aliment Pharm Ther"},{"issue":"5","key":"2613_CR22","doi-asserted-by":"publisher","first-page":"S-146","DOI":"10.1016\/S0016-5085(12)60549-6","volume":"142","author":"F Megraud","year":"2012","unstructured":"Megraud F, Coenen S, Versporten A, Kist M, Lopez-Brea M, Hirschl A, et al. Helicobacter pylori Resistance to antibiotics in europe and its relationship to antibiotic consumption. Gastroenterology. 2012;142(5):S-146.","journal-title":"Gastroenterology"},{"issue":"3","key":"2613_CR23","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.gtc.2015.05.003","volume":"44","author":"DY Graham","year":"2015","unstructured":"Graham DY, Lee SY. How to effectively use bismuth quadruple therapy: the good, the bad, and the ugly. Gastroenterol Clin N. 2015;44(3):537\u201363.","journal-title":"Gastroenterol Clin N"},{"issue":"2","key":"2613_CR24","doi-asserted-by":"publisher","first-page":"77","DOI":"10.23736\/S1121-421X.17.02369-8","volume":"63","author":"DY Graham","year":"2017","unstructured":"Graham DY, Fagoonee S, Pellicano R. Increasing role for modified bismuth-containing quadruple therapies for Helicobacter pylori eradication. Minerva Gastroentero. 2017;63(2):77\u20139.","journal-title":"Minerva Gastroentero"},{"issue":"7","key":"2613_CR25","doi-asserted-by":"publisher","first-page":"780.e5","DOI":"10.1016\/j.cmi.2017.11.010","volume":"24","author":"DS Liu","year":"2018","unstructured":"Liu DS, Wang YH, Zeng ZR, Zhang ZY, Lu H, Xu JM, et al. Primary antibiotic resistance of Helicobacter pylori in Chinese patients: a multiregion prospective 7-year study. Clin Microbiol Infect. 2018;24(7):780.e5-.e8.","journal-title":"Clin Microbiol Infect"},{"key":"2613_CR26","doi-asserted-by":"crossref","unstructured":"Hays C, Burucoa C, Lehours P, Tran CT, Leleu A, Raymond J. Molecular characterization of Helicobacter pylori resistance to rifamycins. Helicobacter. 2018;23(1):e12451.","DOI":"10.1111\/hel.12451"},{"issue":"7","key":"2613_CR27","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.cgh.2018.03.013","volume":"16","author":"HB El-Serag","year":"2018","unstructured":"El-Serag HB, Kao JY, Kanwal F, Gilger M, LoVecchio F, Moss SF, et al. Houston consensus conference on testing for Helicobacter pylori Infection in the United States. Clin Gastroenterol H. 2018;16(7):992-1002.e6.","journal-title":"Clin Gastroenterol H"},{"issue":"8","key":"2613_CR28","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.cmi.2016.06.003","volume":"22","author":"A Ducournau","year":"2016","unstructured":"Ducournau A, B\u00e9n\u00e9jat L, Sifr\u00e9 E, Bess\u00e8de E, Lehours P, M\u00e9graud F. Helicobacter pylori resistance to antibiotics in 2014 in France detected by phenotypic and genotypic methods. Clin Microbiol Infect. 2016;22(8):715\u20138.","journal-title":"Clin Microbiol Infect"},{"key":"2613_CR29","volume":"148","author":"B Wang","year":"2018","unstructured":"Wang B, Zhao Q, Yin W, Yuan Y, Wang X, Wang YH, et al. In-vitro characterisation of a novel antimicrobial agent, TNP-2092, against Helicobacter pylori clinical isolates. Swiss Med Wkly. 2018;148: w14630.","journal-title":"Swiss Med Wkly"},{"issue":"5","key":"2613_CR30","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1093\/jac\/dkm039","volume":"59","author":"E Glocker","year":"2007","unstructured":"Glocker E, Bogdan C, Kist M. Characterization of rifampicin-resistant clinical Helicobacter pylori isolates from Germany. J Antimicrob Chemother. 2007;59(5):874\u20139.","journal-title":"J Antimicrob Chemother"},{"key":"2613_CR31","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1099\/jmm.0.011270-0","volume":"58","author":"SA Chisholm","year":"2009","unstructured":"Chisholm SA, Owen RJ. Frequency and molecular characteristics of ciprofloxacin- and rifampicin-resistant Helicobacter pylori from gastric infections in the UK. J Med Microbiol. 2009;58:1322\u20138.","journal-title":"J Med Microbiol"},{"issue":"8","key":"2613_CR32","first-page":"485","volume":"34","author":"Technical Guidance Group of the Fifth National TB Epidemiological Survey","year":"2012","unstructured":"Technical Guidance Group of the Fifth National TB Epidemiological Survey. The fifth national tuberculosis epidemiological survey in 2010. Chin J Antituberc. 2012;34(8):485\u2013508 (In Chinese).","journal-title":"Chin J Antituberc"},{"key":"2613_CR33","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.2217\/fmb-2020-0084","volume":"15","author":"L Boyanova","year":"2020","unstructured":"Boyanova L, Markovska R, Hadzhiyski P, Kandilarov N, Mitov I. Rifamycin use for treatment of Helicobacter pylori infection: a review of recent data. Future Microbiol. 2020;15:1185\u201396.","journal-title":"Future Microbiol"}],"container-title":["BMC Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-022-02613-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12866-022-02613-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-022-02613-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T09:03:22Z","timestamp":1660381402000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmicrobiol.biomedcentral.com\/articles\/10.1186\/s12866-022-02613-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,13]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2613"],"URL":"https:\/\/doi.org\/10.1186\/s12866-022-02613-y","relation":{},"ISSN":["1471-2180"],"issn-type":[{"value":"1471-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,13]]},"assertion":[{"value":"30 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study has been approval by Biomedicine Ethics Committee of West China Hospital for collection of gastric tissues and for entire study protocol. All methods were conducted in accordance with the principles of the Declaration of Helsinki. Informed consent has been obtained from all subjects and\/or their legal guardians.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participant"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"196"}}